MedTrace Logo

Fecal Transplantation in Ulcerative Colitis

NCT03561532 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2019-08-15

No results posted yet for this study

Summary

Adult individuals with ulcerative colitis in remission are given a single fecal microbiota transplantation (FMT) in colonoscopy. A half of the patients will receive autologous FMT as a placebo and a half will receive an FMT from a healthy donor.

Conditions

Interventions

OTHER

Fecal microbiota transplantation (FMT)

FMT administered into the cecum of the patient in colonoscopy.

OTHER

Placebo

Autologous FMT (fecal suspension made of patients own feces) administered into the cecum of the patient in colonoscopy.

Sponsors & Collaborators

  • Helsinki University Central Hospital

    collaborator OTHER

  • University of Helsinki

    collaborator OTHER

  • Joint Authority for Päijät-Häme Social and Health Care

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-01
Primary Completion
2020-05-31
Completion
2020-05-31

Countries

  • Finland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03561532 on ClinicalTrials.gov